Amrutanjan Historical Income Statement

AMRUTANJAN

666.00 7.95 1.18%

Historical analysis of Amrutanjan Health income statement accounts such as Interest Expense of 2.1 M, Total Revenue of 5.1 B or Gross Profit of 1.3 B can show how well Amrutanjan Health Care performed in making a profits. Evaluating Amrutanjan Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Amrutanjan Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Amrutanjan Health Care latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Amrutanjan Health Care is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amrutanjan Health Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Amrutanjan Income Statement Analysis

Amrutanjan Health Care Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Amrutanjan Health shareholders. The income statement also shows Amrutanjan investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Amrutanjan Health Income Statement Chart

At this time, Amrutanjan Health's Selling General Administrative is very stable compared to the past year. As of the 31st of January 2025, Interest Income is likely to grow to about 178.8 M, while Depreciation And Amortization is likely to drop about 35.2 M.

Total Revenue Gross Profit Other Operating Expenses Operating Income

Total Revenue

Total revenue comprises all receipts Amrutanjan Health Care generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Amrutanjan Health Care minus its cost of goods sold. It is profit before Amrutanjan Health operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Amrutanjan Health Care. It is also known as Amrutanjan Health overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Amrutanjan Health Care operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Amrutanjan Health Care is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Amrutanjan Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Amrutanjan Health Care current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amrutanjan Health Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

	2022	2023	2024	2025 (projected)
Interest Expense	771K	2.5M	2.3M	2.1M
Depreciation And Amortization	52.1M	60.6M	69.7M	35.2M

Interest Expense Depreciation And Amortization

Amrutanjan Health income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Selling And Marketing Expenses	Research Development	Net Income From Continuing Ops	Discontinued Operations	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		-0.09	0.65	0.71	0.67	0.49	0.51	0.55	0.68	0.67	0.52	0.03	0.54	0.37	0.5	0.67	0.5	0.51	-0.58	0.41	0.5	-0.45	0.88
Interest Expense	-0.09		-0.52	-0.54	-0.52	-0.45	-0.46	-0.45	-0.48	-0.51	-0.48	-0.52	-0.46	-0.57	-0.22	-0.61	-0.71	-0.45	0.52	-0.21	-0.23	0.13	-0.39
Total Revenue	0.65	-0.52		0.84	1.0	0.91	0.77	0.78	0.99	0.97	0.77	0.33	0.8	0.87	0.58	0.88	0.79	0.81	-0.8	0.68	0.58	-0.67	0.81
Gross Profit	0.71	-0.54	0.84		0.82	0.82	0.93	0.94	0.81	0.75	0.93	0.54	0.93	0.81	0.31	0.95	0.86	0.91	-0.78	0.73	0.25	-0.6	0.76
Other Operating Expenses	0.67	-0.52	1.0	0.82		0.87	0.71	0.73	1.0	0.98	0.71	0.28	0.75	0.82	0.62	0.86	0.79	0.76	-0.78	0.62	0.63	-0.64	0.84
Operating Income	0.49	-0.45	0.91	0.82	0.87		0.89	0.89	0.87	0.83	0.89	0.34	0.91	0.97	0.48	0.83	0.66	0.93	-0.72	0.89	0.41	-0.79	0.63
Ebit	0.51	-0.46	0.77	0.93	0.71	0.89		1.0	0.71	0.62	1.0	0.59	1.0	0.89	0.18	0.87	0.74	0.99	-0.75	0.88	0.08	-0.69	0.57
Ebitda	0.55	-0.45	0.78	0.94	0.73	0.89	1.0		0.73	0.64	1.0	0.57	1.0	0.89	0.2	0.88	0.74	0.99	-0.76	0.88	0.11	-0.69	0.6
Cost Of Revenue	0.68	-0.48	0.99	0.81	1.0	0.87	0.71	0.73		0.98	0.71	0.26	0.75	0.82	0.62	0.86	0.77	0.77	-0.8	0.64	0.64	-0.65	0.84
Total Operating Expenses	0.67	-0.51	0.97	0.75	0.98	0.83	0.62	0.64	0.98		0.62	0.14	0.66	0.77	0.71	0.81	0.73	0.67	-0.69	0.56	0.74	-0.61	0.85
Income Before Tax	0.52	-0.48	0.77	0.93	0.71	0.89	1.0	1.0	0.71	0.62		0.59	1.0	0.9	0.19	0.88	0.74	0.99	-0.75	0.88	0.09	-0.68	0.58
Total Other Income Expense Net	0.03	-0.52	0.33	0.54	0.28	0.34	0.59	0.57	0.26	0.14	0.59		0.59	0.43	-0.3	0.46	0.6	0.56	-0.57	0.31	-0.44	-0.12	0.08
Net Income	0.54	-0.46	0.8	0.93	0.75	0.91	1.0	1.0	0.75	0.66	1.0	0.59		0.9	0.21	0.88	0.74	0.99	-0.79	0.88	0.12	-0.7	0.59
Income Tax Expense	0.37	-0.57	0.87	0.81	0.82	0.97	0.89	0.89	0.82	0.77	0.9	0.43	0.9		0.39	0.82	0.7	0.92	-0.68	0.88	0.31	-0.75	0.56
Selling General Administrative	0.5	-0.22	0.58	0.31	0.62	0.48	0.18	0.2	0.62	0.71	0.19	-0.3	0.21	0.39		0.37	0.17	0.23	-0.25	0.31	0.81	-0.45	0.64
Selling And Marketing Expenses	0.67	-0.61	0.88	0.95	0.86	0.83	0.87	0.88	0.86	0.81	0.88	0.46	0.88	0.82	0.37		0.91	0.87	-0.83	0.68	0.43	-0.5	0.8
Research Development	0.5	-0.71	0.79	0.86	0.79	0.66	0.74	0.74	0.77	0.73	0.74	0.6	0.74	0.7	0.17	0.91		0.72	-0.79	0.44	0.3	-0.29	0.66
Net Income From Continuing Ops	0.51	-0.45	0.81	0.91	0.76	0.93	0.99	0.99	0.77	0.67	0.99	0.56	0.99	0.92	0.23	0.87	0.72		-0.79	0.9	0.14	-0.73	0.6
Discontinued Operations	-0.58	0.52	-0.8	-0.78	-0.78	-0.72	-0.75	-0.76	-0.8	-0.69	-0.75	-0.57	-0.79	-0.68	-0.25	-0.83	-0.79	-0.79		-0.51	-0.31	0.4	-0.68
Tax Provision	0.41	-0.21	0.68	0.73	0.62	0.89	0.88	0.88	0.64	0.56	0.88	0.31	0.88	0.88	0.31	0.68	0.44	0.9	-0.51		0.14	-0.85	0.47
Interest Income	0.5	-0.23	0.58	0.25	0.63	0.41	0.08	0.11	0.64	0.74	0.09	-0.44	0.12	0.31	0.81	0.43	0.3	0.14	-0.31	0.14		-0.2	0.68
Net Interest Income	-0.45	0.13	-0.67	-0.6	-0.64	-0.79	-0.69	-0.69	-0.65	-0.61	-0.68	-0.12	-0.7	-0.75	-0.45	-0.5	-0.29	-0.73	0.4	-0.85	-0.2		-0.55
Reconciled Depreciation	0.88	-0.39	0.81	0.76	0.84	0.63	0.57	0.6	0.84	0.85	0.58	0.08	0.59	0.56	0.64	0.8	0.66	0.6	-0.68	0.47	0.68	-0.55

Click cells to compare fundamentals

Amrutanjan Health Account Relationship Matchups

Amrutanjan Health income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	36.7M	38.0M	52.1M	60.6M	69.7M	35.2M
Interest Expense	5M	4.8M	771K	2.5M	2.3M	2.1M
Total Revenue	3.3B	4.1B	3.8B	4.2B	4.8B	5.1B
Gross Profit	1.9B	2.2B	2.0B	2.1B	2.4B	1.3B
Other Operating Expenses	2.6B	3.3B	3.4B	3.8B	4.3B	4.5B
Operating Income	717.9M	798.4M	418.5M	621.0M	714.2M	749.9M
Ebit	825.0M	909.0M	538.7M	621.0M	714.2M	376.4M
Ebitda	861.7M	947.0M	590.8M	681.6M	783.8M	411.6M
Cost Of Revenue	1.4B	1.8B	1.8B	2.1B	2.4B	2.6B
Total Operating Expenses	1.2B	1.5B	1.6B	2.1B	2.4B	2.5B
Income Before Tax	819.0M	905.8M	536.5M	619.5M	712.4M	370.7M
Total Other Income Expense Net	101.1M	107.4M	117.9M	(1.6M)	(1.8M)	(1.7M)
Net Income	611.9M	671.9M	398.3M	449.7M	517.2M	303.7M
Income Tax Expense	207.1M	233.9M	138.1M	169.7M	195.2M	205.0M
Selling General Administrative	24.4M	27.3M	44.6M	262.7M	302.1M	317.2M
Selling And Marketing Expenses	555.9M	729.4M	525.8M	734.9M	845.1M	480.1M
Research Development	8.7M	11.3M	12.0M	11.3M	13.0M	8.4M
Net Income From Continuing Ops	611.9M	671.9M	398.3M	449.7M	517.2M	352.6M
Net Income Applicable To Common Shares	250.8M	611.9M	671.9M	398.3M	458.1M	337.5M
Tax Provision	207.1M	233.9M	138.1M	169.7M	195.2M	160.6M
Interest Income	5M	4.8M	771K	148.0M	170.3M	178.8M
Net Interest Income	(5M)	(4.8M)	(771K)	(1.6M)	(1.4M)	(1.3M)
Reconciled Depreciation	36.7M	38.0M	52.1M	60.6M	69.7M	46.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

Other Information on Investing in Amrutanjan Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Amrutanjan Historical Income Statement

About Amrutanjan Income Statement Analysis

Amrutanjan Health Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Operating Income

Amrutanjan Health income statement Correlations

Amrutanjan Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Amrutanjan Health income statement Accounts

Also Currently Popular

Other Information on Investing in Amrutanjan Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Net Income	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebitda

Net Interest Income	- 0.85	Tax Provision
Discontinued Operations	- 0.83	Selling And Marketing Expenses
Discontinued Operations	- 0.8	Cost Of Revenue
Discontinued Operations	- 0.8	Total Revenue
Discontinued Operations	- 0.79	Net Income From Continuing Ops
Discontinued Operations	- 0.79	Research Development